# SEROQUEL XR
> **NDA022172** · New Drug Application · Sponsor: CHEPLAPHARM ARZNEIMITTEL GMBH · Approved 2007-11-15
## Drug
- **FDA Application Number:** NDA022172
- **Application type:** New Drug Application
- **Brand name:** SEROQUEL XR
- **Generic name:** Quetiapine Fumarate
- **Active ingredients:** QUETIAPINE FUMARATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHEPLAPHARM ARZNEIMITTEL GMBH
- **First approval:** 2007-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022172)
---
*AI Analytics · CC0 1.0*